当前位置:药药网 / 药品研发 / 美国药品上市后承诺数据库
DENGVAXIA, Dengue Tetravalent Vaccine, Live
药品名称
DENGVAXIA, Dengue Tetravalent Vaccine, Live
承诺描述
Deferred study CYD57 to evaluate the safety and effectiveness of DENGVAXIA in children 4 to less than 9 years of age.
承诺状态描述
The study is ongoing.